C. Lindoff

发表

Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial

K. Maršál, H. Hagberg, I. Kjellmer, 2001, The Lancet.

Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.

B. Norrving, B. Johansson, A. Lindgren, 1996, Stroke.

Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161)

C. Lindoff, B. Åstedt, B. Schoultz, 1995, British journal of obstetrics and gynaecology.

Passage of the menopause is followed by haemostatic changes.

C. Lindoff, B. Åstedt, G. Martinsson, 1993, Maturitas.

Treatment with Tranexamic Acid during Pregnancy, and the Risk of Thrombo-Embolic Complications

C. Lindoff, B. Åstedt, G. Rybo, 1993, Thrombosis and Haemostasis.

Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.

C. Lindoff, B. Åstedt, G. Martinsson, 1996, Maturitas.

Preeclampsia is associated with a reduced response to activated protein C.

I. Ingemarsson, H. Thysell, C. Lindoff, 1997, American journal of obstetrics and gynecology.

Brain-specific NSE and S-100 proteins in umbilical blood after normal delivery.

K. Maršál, C. Alling, I. Amer-Wåhlin, 2001, Clinica chimica acta; international journal of clinical chemistry.

Plasminogen activator of urokinase type and its inhibitor of placental type in hypertensive pregnancies and in intrauterine growth retardation: possible markers of placental function.

C. Lindoff, B. Åstedt, 1994, American journal of obstetrics and gynecology.

Diclofenac versus pethidine in the treatment of pain after hysterectomy.

C. Lindoff, A. Hellman, L. Carlborg, 1987, European journal of anaesthesiology.

Difference in mRNA expression and occurrence of plasminogen activator inhibitors in intrauterine decidua of normal and ectopic human pregnancies.

S. Hansson, C. Lindoff, A. Jonasson, 1999, Human fertility.

Significance of the Plasminogen Activator Inhibitor of Placental Type (PAI-2) In Pregnancy

C. Lindoff, B. Åstedt, I. Lecander, 1998, Seminars in thrombosis and hemostasis.

Treatment with a GnRH analogue: effects on hemostatic risk factors for thrombo-embolic disease.

C. Lindoff, G. Samsioe, B. Åstedt, 1994, International journal of fertility and menopausal studies.

Fibrinolytic components in individual consecutive plasma samples during normal pregnancy

C. Lindoff, B. Åstedt, I. Lecander, 1993 .

Plasminogen activators and plasminogen activator inhibitors in plasma of premature and term newborns

C. Lindoff, B. Åstedt, 1997, Acta paediatrica.